Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement

Por Collins, G S, Reitsma, J B, Altman, D G, Moons, K G M
Publicado no Br J Cancer (2015)

Interpretation of CVD risk predictions in clinical practice: Mission impossible?

Por Lagerweij, G. R., Moons, K. G. M., de Wit, G. A., Koffijberg, H.
Publicado no PLoS One (2019)

The FOLLOWPACE study: a prospective study on the (cost-)effectiveness of routine follow-up visits in patients with a pacemaker

Por van Eck, J.W.M., Grobbee, D.E., van Hemel, N.M., Moons, K.G.M.
Publicado em 2004

Including post-discharge mortality in calculation of hospital standardised mortality ratios: retrospective analysis of hospital episode statistics

Por Pouw, Maurice E, Peelen, L M, Moons, K G M, Kalkman, C J, Lingsma, H F
Publicado em 2013

Markers for the non-invasive diagnosis of mesothelioma: a systematic review

Por van der Bij, S, Schaake, E, Koffijberg, H, Burgers, J A, de Mol, B A J M, Moons, K G M
Publicado em 2011

Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis

Por Geersing, G J, Janssen, K J M, Oudega, R, Bax, L, Hoes, A W, Reitsma, J B, Moons, K G M
Publicado em 2009

Tailoring the Implementation of New Biomarkers Based on Their Added Predictive Value in Subgroups of Individuals

Por van Giessen, A., Moons, K. G. M., de Wit, G. A., Verschuren, W. M. M., Boer, J. M. A., Koffijberg, H.
Publicado no PLoS One (2015)

Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibrom...

Por Cnossen, M H, Moons, K G, Garssen, M P, Pasmans, N M, de Goede-Bolder, A, Niermeijer, M F, Grobbee, D E
Publicado em 1998

Prognosis and prognostic factors of patients with mesothelioma: a population-based study

Por van der Bij, S, Koffijberg, H, Burgers, J A, Baas, P, van de Vijver, M J, de Mol, B A J M, Moons, K G M
Publicado em 2012

The Dutch Hospital Standardised Mortality Ratio (HSMR) method and cardiac surgery: benchmarking in a national cohort using hospital administration data versus a clinical database

Por Siregar, S, Pouw, M E, Moons, K G M, Versteegh, M I M, Bots, M L, van der Graaf, Y, Kalkman, C J, van Herwerden, L A, Groenwold, R H H
Publicado em 2014

Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule

Por Vergouwe, Y., Soedamah-Muthu, S. S., Zgibor, J., Chaturvedi, N., Forsblom, C., Snell-Bergeon, J. K., Maahs, D. M., Groop, P.-H., Rewers, M., Orchard, T. J., Fuller, J. H., Moons, K. G. M.
Publicado em 2009

Association between early and three month cognitive outcome after off-pump and on-pump coronary bypass surgery

Por van Dijk, D, Moons, K G M, Keizer, A M A, Jansen, E W L, Hijman, R, Diephuis, J C, Borst, C, de Jaegere, P P T, Grobbee, D E, Kalkman, C J
Publicado em 2004

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes

Por van Dieren, S., Peelen, L. M., Nöthlings, U., van der Schouw, Y. T., Rutten, G. E. H. M., Spijkerman, A. M. W., van der A, D. L., Sluik, D., Boeing, H., Moons, K. G. M., Beulens, J. W. J.
Publicado em 2010

Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis

Por Geersing, G J, Zuithoff, N P A, Kearon, C, Anderson, D R, ten Cate-Hoek, A J, Elf, J L, Bates, S M, Hoes, A W, Kraaijenhagen, R A, Oudega, R, Schutgens, R E G, Stevens, S M, Woller, S C, Wells, P S, Moons, K G M
Publicado em 2014

Long-Term Cognitive Impairment after Critical Illness

Por Pandharipande, P.P., Girard, T.D., Jackson, J.C., Morandi, A., Thompson, J.L., Pun, B.T., Brummel, N.E., Hughes, C.G., Vasilevskis, E.E., Shintani, A.K., Moons, K.G., Geevarghese, S.K., Canonico, A., Hopkins, R.O., Bernard, G.R., Dittus, R.S., Ely, E.W.
Publicado em 2013

Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative

Por den Ruijter, H. M., Peters, S. A. E., Groenewegen, K. A., Anderson, T. J., Britton, A. R., Dekker, J. M., Engström, G., Eijkemans, M. J., Evans, G. W., de Graaf, J., Grobbee, D. E., Hedblad, B., Hofman, A., Holewijn, S., Ikeda, A., Kavousi, M., Kitagawa, K., Kitamura, A., Koffijberg, H., Ikram, M. A., Lonn, E. M., Lorenz, M. W., Mathiesen, E. B., Nijpels, G., Okazaki, S., O'Leary, D. H., Polak, J. F., Price, J. F., Robertson, C., Rembold, C. M., Rosvall, M., Rundek, T., Salonen, J. T., Sitzer, M., Stehouwer, C. D. A., Witteman, J. C., Moons, K. G., Bots, M. L.
Publicado no Diabetologia (2013)